Blockchain

Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding

PFAFFIKON, SWITZERLAND, Jan 6, 2024 – (ACN Newswire) – Spiden, a pioneer in non-invasive biomarker monitoring technology, is thrilled to announce a significant scientific milestone, key additions to its executive team and an oversubscribed convertible note. Spiden’s latest non-invasive glucose measurement campaignSpiden’s latest glucose measurement data comparing its non-invasive portable device (y-axis) with the invasive gold-standard (x-axis), illustrated in the

Read More »
Blockchain

BioMed X Launches a New Call for Application in Autoimmune Disease Research

HEIDELBERG, Germany, Nov 7, 2023 – (ACN Newswire) – BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease. Current therapeutic strategies for autoimmune diseases primarily focus on

Read More »
Blockchain

EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine

LONDON, Oct 27, 2023 – (ACN Newswire) – EW Healthcare Partners announced that it has acquired a c. 25% minority stake in Boiron Developpement, an entity formed for the purposes of launching a tender offer for the Boiron Group, in partnership with the Boiron Family, at a c. €875 million enterprise value. As part of this transaction, the Boiron family

Read More »
Blockchain

Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China’s Top 100 Pharmaceutical Innovative Enterprises in 2023

Hong Kong, Oct 13, 2023 – (ACN Newswire) – Sihuan Pharmaceutical Holdings Group Ltd. (the “Company” or “Sihuan Pharmaceutical”, together with its subsidiaries, the “Group”, HKEX stock code: 0460) is pleased to announce that, Huisheng Biopharmaceutical, Co., Ltd. (“Huisheng Biopharmaceutical”), a non-wholly owned subsidiary of the Group, was selected as one of the first echelon of enterprises in The list

Read More »
Blockchain

ZeptoMetrix Awarded in Vitro Diagnostic Regulation (IVDR) Certification

BUFFALO, NY, Oct 3, 2023 – (ACN Newswire) – ZeptoMetrix® is pleased to announce it has been awarded an IVDR Quality Management System certificate from British Standards Institution BSI, NB 2797, one of the notified bodies under the new EU In Vitro Diagnostics Regulation (IVDR). This certificate applies to the majority of the current portfolio of CE marked ZeptoMetrix NATtrol™

Read More »
Blockchain

Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery

NEW YORK, NY / ACN Newswire / September 19, 2023 / InSyBio, a leading biotechnology company that has developed a suite of advanced AI tools for biomarker discovery in clinical and multi-omics data, has announced a strategic partnership with Syndesis Health, a leader in global real-world evidence. The partnership aims to leverage the clinical and genomic data on Syntium, Syndesis’

Read More »
Blockchain

Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results

HONG KONG, Aug 25, 2023 – (ACN Newswire) – Sino Biopharmaceutical Limited (“Sino Biopharmaceutical” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2023 (the “Period”). Development Highlights— In the second quarter, the Group capitalized on the post-COVID recovery, vigorously developed its

Read More »

Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients

BARCELONA, July 28, 2023 – (ACN Newswire) – Peptomyc S.L., a biotech company specialized in the development of protein therapeutics for cancer treatment, announces that it has received full study approval for its new Phase 1b clinical trial, which will evaluate the combination of the first-in-class MYC inhibitor, OMO103, together with the standard of care (SoC) regimen Gemcitabine and Nab-Paclitaxel in metastatic Pancreatic Ductal

Read More »
Blockchain

Cure Brain Cancer Foundation Unveils Fellowship Awardees

SYDNEY, AU, June 30, 2023 – (ACN Newswire) – Cure Brain Cancer Foundation (CBCF) is pleased to announce the highly anticipated recipients of this year’s prestigious Early Career Fellowships. This unrivaled funding opportunity is set to empower researchers, propelling them closer to breakthrough discoveries in the battle against brain cancer. Designed to fuel cutting-edge research initiatives, CBCF research grants are championing advancements that hold

Read More »
Blockchain

Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA

HONG KONG, June 27, 2023 – (ACN Newswire) – Sihuan Pharmaceutical Holdings Group Ltd. (the “Company” or “Sihuan Pharmaceutical”, together with its subsidiaries, the “Group”, HKEX stock code: 0460) is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd. (“Xuanzhu Biopharm”), a non-wholly owned subsidiary of Company, has received a drug registration approval from the National Medical Products Administration (the “NMPA”) of China of Anaprozole

Read More »
Blockchain

Proventus Bioscience Breaks Ground on Its New Production Facility and Expansion of Its Laboratories and Fermentation Plant

MONTREAL, QUEBEC, June 13, 2023 – (ACN Newswire) – Proventus Bioscience, a biotech company that produces sustainable biological microorganisms for use by various industries, announced the start of construction of its new 20,000-square-foot production plant and corporate headquarters at 4455 Griffith St., Saint-Laurent, QC. Proventus’ new 20,000-square foot facility is designed to be compliant with current Good Manufacturing Practices (camps) required by the food

Read More »
Blockchain

SinoMab Submits another IND Application for SM17 for the Treatment of Atopic Dermatitis, Which was Accepted by NMPA CDE

HONG KONG, June 12, 2023 – (ACN Newswire) – A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases – SinoMab BioScience Limited (Stock Code: 3681.HK, “SinoMab” or the “Company”), is pleased to announce that an Investigational New Drug application (“IND”) for SM17, a humanised anti-IL-17RB monoclonal antibody for injection, for atopic dermatitis

Read More »
Blockchain

Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy Published in the New England Journal of Medicine

ZURICH, SWITZERLAND, May 22, 2023 – (ACN Newswire) – Neurimmune announced today that primary results of its Phase 1 proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR cardiomyopathy, have been presented in Prague at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC), and published in The New England Journal of Medicine (DOI: 10.1056/NEJMoa2303765).

Read More »
Blockchain

Fertilix Proven Effective in Blocking Damage From Low-Dose Exposure to Chemicals Commonly Found in Plastic Consumer Products

CLERMONT-FERRAND, FRANCE, May 19, 2023 – (ACN Newswire) – According to a recent study by Universite Clermont Auvergne researchers, exposure to chemical additives and building blocks commonly used in everyday plastic products, even in low doses, can cause significant damage to the genetic material carried by sperm cells. Fertilix(R) logo The study, led by Professor Joel Drevet, examined two common chemicals widely used in

Read More »
Blockchain

Endurance RP: Excellent Positive Results from Phase 3 Randomised Clinical Trial of Fortacin(TM)/Senstend(TM) in China

HONG KONG, Apr 17, 2023 – (ACN Newswire) – Endurance RP Limited (“Endurance” or the “Company” and collectively with its subsidiaries, the “Group”; stock code: 0575.HK) is pleased to announce its commercial strategic partner Wanbang Biopharmaceutical Co., Ltd. (“Wanbang Biopharmaceutical”) has successfully completed the Phase 3 double-blind placebo-controlled study of Senstend(TM) in China for the treatment of premature ejaculation (“PE”). The study recorded excellent

Read More »
Blockchain

Q’Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter

FREMONT, CA, Mar 28, 2023 – (ACN Newswire) – Q’Apel Medical Inc. was granted the CE Mark under MDR for Walrus, their U.S. market-leading Balloon Guide Catheter (BGC) utilized in treating patients suffering an acute ischemic stroke. The Walrus BGC has been utilized by Neuro Interventional physicians since 2019 and has successfully treated over 20,000 patients in the United States. The Walrus BGC is

Read More »
Blockchain

EC Healthcare Collaborates with New Horizon Health to form Strategic Partnership To Jointly Launch CerviClear in Hong Kong

HONG KONG, Mar 24, 2023 – (ACN Newswire) – EC Healthcare (2138.HK) and New Horizon Health (6606.HK) host ceremony today to form an exclusive strategic partnership. Both parties will consolidate the resources to empower the launching, distribution, and promotion of CerviClear in Hong Kong. It is expected this home-use cancer screening product will help to increase the awareness penetration of Cervical cancer prevention, and

Read More »
Blockchain

OrbusNeich Announces First Annual Results After Listing, Record Revenue of US$136.8 Million, Adjusted Net Profit Up 25% to US$26.7 Million

HONG KONG, Mar 8, 2023 – (ACN Newswire) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, today announced its first annual results after its listing on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEX”)

Read More »
Blockchain

EC Healthcare Opened the First Organic Flagship Veterinary Hospital in Hong Kong

HONG KONG, Mar 6, 2023 – (ACN Newswire) – EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group opened its first organic flagship veterinary hospital, Animal Medical Academy Hospital (AMAH). From left to right: Dr. Guo Shanshan, Co-Principal of

Read More »
Blockchain

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

LONDON AND HONG KONG, Mar 4, 2023 – (ACN Newswire) – Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the ‘SAB’) to provide strategic input based on their scientific knowledge and clinical expertise to help guide the further development of Prenetics’ diagnostic cancer genomics platform. Prenetics has

Read More »

Kingworld Medicines Earns “Shenzhen Time-honored Brand” Title Again

HONG KONG, Feb 28, 2023 – (ACN Newswire) – Headquartered in Shenzhen, Kingworld Medicines Group Limited (stock code: 01110.HK) is a distributor and the agent of many well-known and high-quality health products, providing channels and supply chains to the products. It has helped brands establish professional image and achieved good sales performance in the Mainland China, Hong Kong and Macau markets, gaining the endorsement

Read More »

Accessibility Dashboard

Accessibility settings have been reset

Help = available voice commands

Hide help = available voice commands

Scroll down = available voice commands

Scroll up = available voice commands

Go to top = available voice commands

Go to bottom = available voice commands

Tab = available voice commands

Tab back = available voice commands

Show numbers = available voice commands

Hide numbers = available voice commands

Clear input = available voice commands

Enter = available voice commands

Reload = available voice commands

Stop = available voice commands

Exit = available voice commands